EU to buy up to 300 million doses of Pfizer-BioNTech vaccine

The European Commission will sign a deal to secure up to 300 million doses of the experimental coronavirus vaccine developed by BioNTech and Pfizer

“This is the most promising vaccine so far,” von der Leyen said. “Once this vaccine becomes available, our plan is to deploy it quickly, everywhere in Europe.”

Pfizer said Monday that early results from the vaccine suggests the shots may be a surprisingly robust 90% effective at preventing COVID-19.

The European Commission had already secured three other deals with pharmaceutical companies allowing its 27 member states to buy nearly one billion doses of a potential coronavirus vaccine.

BioNTech said Tuesday that it and Pfizer have so far signed commercial supply agreements for 570 million doses in 2020 and 2021, with options to purchase an additional 600 million doses.

Top Stories

Top Stories

Top Stories

Top Stories

ABC News Live

ABC News Live

24/7 coverage of breaking news and live events